[go: up one dir, main page]

IE781222L - Prostacyclin analogues - Google Patents

Prostacyclin analogues

Info

Publication number
IE781222L
IE781222L IE781222A IE122278A IE781222L IE 781222 L IE781222 L IE 781222L IE 781222 A IE781222 A IE 781222A IE 122278 A IE122278 A IE 122278A IE 781222 L IE781222 L IE 781222L
Authority
IE
Ireland
Prior art keywords
prostacyclin
agents
pharmacological
prostacyclin analogues
us4097489a
Prior art date
Application number
IE781222A
Other versions
IE47199B1 (en
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of IE781222L publication Critical patent/IE781222L/en
Publication of IE47199B1 publication Critical patent/IE47199B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention relates to certain structural and pharmacological analogs of prostacyclin (PGI2) wherein a nitrogen atom is substituted for the 6,9 alpha -epoxy-oxygen of prostacyclin. These novel nitrogen-containing prostacyclin-type compounds are useful for the pharmacological purposes for which prostacyclin is used, e.g., as antithrombotic agents, smooth muscle stimulators, gastric antisecretory agents, antihypertensive agents, antiasthma agents, nasal decongestants, or regulators of fertility and procreation. [US4097489A]
IE1222/78A 1977-06-17 1978-06-16 Prostacyclin analogues IE47199B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/807,514 US4097489A (en) 1977-06-17 1977-06-17 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds

Publications (2)

Publication Number Publication Date
IE781222L true IE781222L (en) 1978-12-17
IE47199B1 IE47199B1 (en) 1984-01-11

Family

ID=25196557

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1222/78A IE47199B1 (en) 1977-06-17 1978-06-16 Prostacyclin analogues

Country Status (16)

Country Link
US (6) US4097489A (en)
JP (1) JPS549265A (en)
AU (1) AU520091B2 (en)
BE (1) BE868202A (en)
CA (1) CA1091227A (en)
CH (1) CH635075A5 (en)
DE (1) DE2826096A1 (en)
FR (1) FR2394530A1 (en)
GB (1) GB1598137A (en)
IE (1) IE47199B1 (en)
IL (1) IL54806A (en)
IT (1) IT1158739B (en)
NL (1) NL7806383A (en)
NZ (1) NZ187393A (en)
SE (1) SE7806927L (en)
ZA (1) ZA783065B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097489A (en) * 1977-06-17 1978-06-27 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds
JPS54125653A (en) * 1978-03-18 1979-09-29 Ono Pharmaceut Co Ltd Prostaglandin i2 analog, its preparation, and drug composition comprising it as active constituent
US4211706A (en) * 1978-10-13 1980-07-08 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-17,18-didehydro-PGF compounds
DE2845770A1 (en) * 1978-10-19 1980-04-30 Schering Ag NEW PROSTACYCLINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
JPS55111465A (en) * 1979-02-20 1980-08-28 Ono Pharmaceut Co Ltd Prostaglandin i2 analog and its preparation
DE2907118A1 (en) * 1979-02-20 1980-09-04 Schering Ag NEW PROSTACYCLINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
US4294759A (en) * 1979-11-15 1981-10-13 The Upjohn Company Structural analogues of 5,6,-dihydro PG1
JPS56111811A (en) * 1980-02-11 1981-09-03 Toshiba Corp Light signal branching device
DE3006865A1 (en) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt HETERO-IMINO-PROSTACYCLINE
US4472428A (en) * 1980-12-09 1984-09-18 Teijin Limited Halogenated prostacyclins pharmaceutical use thereof and hydroxy intermediates therefore
DE3107100A1 (en) * 1981-02-20 1982-09-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen AZAPROSTACYCLINE, METHOD FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE
DE3267651D1 (en) * 1981-04-02 1986-01-09 Searle & Co 5 fluoro pgi compounds
US4702261A (en) * 1985-07-03 1987-10-27 Sherwood Medical Company Biopsy device and method
ATE101342T1 (en) 1988-09-06 1994-02-15 Kabi Pharmacia Ab PROSTAGLAND INDIVIDUALS FOR THE TREATMENT OF GREEN STAR OR OCULAR HYPERTENSION.
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
EP0664707B1 (en) * 1992-10-13 1997-06-04 Alcon Laboratories, Inc. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
US5332730A (en) * 1992-10-16 1994-07-26 Allergan, Inc. Azido derivatives of cyclopentane heptanoic or heptenoic acid
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
US5700835A (en) * 1995-12-22 1997-12-23 Alcon Laboratories, Inc. 3-Oxa-D-prostaglandins for lowering IOP
WO1997023225A1 (en) * 1995-12-22 1997-07-03 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US7718697B2 (en) * 2003-12-17 2010-05-18 Alcon, Inc. Method for treating glaucoma comprising administering α-lipoic acid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931289A (en) * 1970-12-31 1976-01-06 The Upjohn Company 3-Oxa phenyl-substituted PGE compounds
US3772312A (en) * 1972-01-31 1973-11-13 Ciba Geigy Corp Octahydropyrindenes
US3983157A (en) * 1974-04-11 1976-09-28 The Upjohn Company 4-Oxa phenyl-substituted PGF compounds
US3983158A (en) * 1974-04-11 1976-09-28 The Upjohn Company 3-Oxa phenyl-substituted PGA compounds
US4324905A (en) * 1974-08-14 1982-04-13 The Upjohn Company Phenacyl-type esters of PGF2α and its 15-methyl analogs
GB1529852A (en) * 1975-03-21 1978-10-25 Labaz 8-azaprostaglandins and process for the preparation thereof
GB1523178A (en) * 1975-04-26 1978-08-31 Tanabe Seiyaku Co 8-azaprostanoic acid derivatives and process for preparing the same
US3983178A (en) * 1975-07-21 1976-09-28 Hooker Chemicals & Plastics Corporation Immonium salts and derivatives thereof
US4097489A (en) * 1977-06-17 1978-06-27 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds

Also Published As

Publication number Publication date
DE2826096A1 (en) 1979-01-04
AU3655778A (en) 1979-12-06
NL7806383A (en) 1978-12-19
ZA783065B (en) 1979-06-27
US4136095A (en) 1979-01-23
JPS549265A (en) 1979-01-24
CH635075A5 (en) 1983-03-15
US4152514A (en) 1979-05-01
AU520091B2 (en) 1982-01-14
IL54806A (en) 1984-02-29
IT7824093A0 (en) 1978-05-31
US4163841A (en) 1979-08-07
NZ187393A (en) 1981-12-15
US4161584A (en) 1979-07-17
IE47199B1 (en) 1984-01-11
FR2394530B1 (en) 1981-02-27
CA1091227A (en) 1980-12-09
SE7806927L (en) 1979-12-16
US4151176A (en) 1979-04-24
FR2394530A1 (en) 1979-01-12
US4097489A (en) 1978-06-27
GB1598137A (en) 1981-09-16
BE868202A (en) 1978-12-18
IT1158739B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
IE781222L (en) Prostacyclin analogues
MY101891A (en) Novel carbostyril derivative and process for preparing same.
EP0165458A3 (en) (+)-ambrox, process for production thereof and use thereof
EP0150709A3 (en) 7-oxabicycloheptane prostaglandin analogs
EP0164040A3 (en) Furan derivatives having anti-ulcer activity
EP0164987A3 (en) 7-oxabicycloheptane substituted prostaglandin analogs
US4088694A (en) 2-Decarboxy-2-hydroxymethyl-11-deoxy-PGE2 analogs
US4076751A (en) 2-Decarboxy-2-hydroxymethyl-3,7-inter-m-phenylene-3-oxa-PGE1 compounds
IE792329L (en) Thiazaheterocyclics and process for preparing pyrrolidine¹and piperidine derivatives.
IE57027B1 (en) 7-oxabicycloheptane substituted prostaglandin analogs
ATE42091T1 (en) N-(6-METHOXY-5(PERFLUORALKYL)-1-NAPHTHOYL)-NMETHYLGLYCINE AND THEIR THIONAPHTHOYLANALOGS.
MY102310A (en) New 5-oxy deravatives of tetrahydrofuran
US4203924A (en) 2-Decarboxy-2-hydroxymethyl-deoxy-9,10-didehydro-PGD2 analogs
CA1262912C (en) Tetrahydrofuranyl substituted prostaglandin analogs
EP0240890A3 (en) Prostacyclin (pgi2) analogues
IE45085L (en) Protected (hydroxy-5-oxocyclopent-1-enyl) heptanes and¹hept-5z-enes
DE3464609D1 (en) Spiro(benzofuran-azalkanes), a method for their preparation and their use as medicaments
EP0088619A3 (en) Benzopyrans
IE45756L (en) Process for the production of 2, 9-dioxatricyclo [4,3,1,0]¹decanes
US4461917A (en) 9-Deoxy-9-methylene-PGE compounds
GB1501319A (en) Polyurethane curing agents derived from 4,4'-methylene-bis(2-chloroaniline)
US4176236A (en) Composition and process
US4144276A (en) 3,7-Inter-phenylene-4,5,6-trinor-3-oxa-2-decarboxy-2-hydroxymethyl-9-deoxy-9-methylene-PGF-type compounds
US4208538A (en) 2-Decarboxy-2-hydroxymethyl-3,7-inter-m-phenylene-ω-phenyl-PGF2 compounds
US4171460A (en) 2-Decarboxy-2-hydroxymethyl-PGF1 α analogs